Musicha, Patrick, Feasey, Nicholas ORCID: https://orcid.org/0000-0003-4041-1405, Cain, Amy, Kallonen, Teemu, Chaguza, Chrispin, Peno, Chikondi, Khonga, Margaret, Thompson, Sarah, Gray, Katherine J, Mather, Alison E, Heyderman, Robert S, Everett, Dean B, Thomson, Nicholas R and Msefula, Chisomo L (2017) 'Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.'. The Journal of Antimicrobial Chemotherapy, Vol 72, Issue 6, pp. 1602-1609.
|
Text
J_Antimicrob_Chemother_dkx058_2017.pdf - Published Version Available under License Creative Commons Attribution. Download (322kB) | Preview |
Abstract
Efforts to treat Escherichia coli infections are increasingly being compromised by the rapid, global spread of antimicrobial resistance (AMR). Whilst AMR in E. coli has been extensively investigated in resource-rich settings, in sub-Saharan Africa molecular patterns of AMR are not well described. In this study, we have begun to explore the population structure and molecular determinants of AMR amongst E. coli isolates from Malawi. Ninety-four E. coli isolates from patients admitted to Queen's Hospital, Malawi, were whole-genome sequenced. The isolates were selected on the basis of diversity of phenotypic resistance profiles and clinical source of isolation (blood, CSF and rectal swab). Sequence data were analysed using comparative genomics and phylogenetics. Our results revealed the presence of five clades, which were strongly associated with E. coli phylogroups A, B1, B2, D and F. We identified 43 multilocus STs, of which ST131 (14.9%) and ST12 (9.6%) were the most common. We identified 25 AMR genes. The most common ESBL gene was bla CTX-M-15 and it was present in all five phylogroups and 11 STs, and most commonly detected in ST391 (4/4 isolates), ST648 (3/3 isolates) and ST131 [3/14 (21.4%) isolates]. This study has revealed a high diversity of lineages associated with AMR, including ESBL and fluoroquinolone resistance, in Malawi. The data highlight the value of longitudinal bacteraemia surveillance coupled with detailed molecular epidemiology in all settings, including low-income settings, in describing the global epidemiology of ESBL resistance.
Item Type: | Article |
---|---|
Subjects: | QU Biochemistry > Genetics > QU 460 Genomics. Proteomics QU Biochemistry > Genetics > QU 500 Genetic phenomena QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 290 Escherichia coli infections |
Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department Clinical Sciences & International Health > International Public Health Department |
Digital Object Identifer (DOI): | https://doi.org/10.1093/jac/dkx058 |
SWORD Depositor: | JISC Pubrouter |
Depositing User: | JISC Pubrouter |
Date Deposited: | 20 Apr 2017 11:23 |
Last Modified: | 06 Feb 2018 13:14 |
URI: | https://archive.lstmed.ac.uk/id/eprint/6982 |
Statistics
Actions (login required)
Edit Item |